Research Innovation Group

Saint Louis University strives to be exceptional at technology transfer and a partner of choice for university research and intellectual property commercialization.

We're service oriented and we strive to be fast, efficient, and helpful. We look forward to learning about your needs and exploring ways that we can help you achieve your goals.

Available for Licensing

Please browse the categories below to learn more about our intellectual property portfolio and identify technologies that may be of interest to you.

Search Intellectual Property Portfolio

ID Intelectual Property Type
ID Intelectual Property Type
04-015 Method for detecting lysosomal storage diseases Diagnostic
07-017 Novel products of myeloperoxidase useful in assessing cardiac health Diagnostic
10-017 Biolayer interferometry measurement of biological targets Diagnostic
10-024 Sickle confirm modified hemoglobin solubility test Diagnostic
00-000 Diagnostic method for biomarkers of adverse coronary events Diagnostic
05-009 Drug delivery from electroactive molecularly imprinted polymer Drug Delivery
10-016 Passivated metal nanoparticles having an epoxide-based oligomer coating Industrial Applications
10-023 Organelle bioelectrodes and methods of making Industrial Applications
10-012 Methods and compositions for decomposition of biomass Industrial Applications
04-001 Intramedullary nail device and method for repairing long bone Medical Devices
05-016 Dental repair material Medical Devices
07-023 Method and apparatus for sutureless injectable retinal detachment sponge implantation Medical Devices
10-011 Method for controlling phase transformation temperature in metal alloy of a device Medical Devices
10-014 Distractor Medical Devices
10-015 Input device, a finger mouse for use in operating rooms Medical Devices
10-02 Method and apparatus for delivery into the fetal trachea Medical Devices
10-037 Locking screw device Medical Devices
12-006 Foreign Body Location and Retrieval Device Medical Devices
02-006 MPS IVa (Morquio A) mouse with point mutation and tolerant of human GALNS Research Tools
05-008 Method of screening for a drug candidate that increases ATP release from RBCs stimulated via the Gs or Gi pathway Research Tools
06-020 Compositions and methods for amplification and cloning of near full-length vial genome samples Research Tools
07-004 Method for improving chemiluminescent signal Research Tools
07-006 Screening tool for antiviral agents Research Tools
10-008 Animal model for Parkinson's disease Research Tools
10-025 Network threading approach for predicting a patient's response to hepatitis C virus therapy Research Tools
11-004 Electronic research collaboration systems and methods Research Tools
98-002 Mouse model for hemochromatosis wherein the HFE gene has been disrupted Research Tools
98-008 C22: a conditionally immortalized mouse Clara cell line Research Tools
98-013 Human NK 3.3 cell line Research Tools
00-011 Factor IXa: Factor VIIIa interaction and methods therefore Therapeutics
01-002 Proteins with an attached short peptide of acidic amino acids Therapeutics
03-013 Method of manufacturing a stellate cell death factor Therapeutics
03-019 Methods and compositions for vaccination Therapeutics
06-002 Polypeptide fragment of constitutive coactivator of PPARgamma Therapeutics
06-013 Chimeral polypeptide composition for cross-placenta delivery Therapeutics
06-030 Methods and compositions for activated Protein C mutant with reduced anticoagulant properties Therapeutics
06-047 Compositions and methods for treating immune system mediated diseases Therapeutics
10-006 Method and composition for the management of cardiovascular disease with oligonucleotides Therapeutics
10-007 Delivery of therapeutic agents to the bone Therapeutics
10-010 Virus-expressing host costimulation molecules Therapeutics
10-018 Peptides for inducing heterosubtypic influenza T cell responses Therapeutics
10-021 Method of treating chronic pain Therapeutics
10-032 Expression of anticoagulant thrombin mutants in Escherichia coli Therapeutics
10-036 Prenatal enzyme replacement therapy Therapeutics
10-038 Compositions and methods of treating disease by stimulating ATP release by red blood cells Therapeutics
11-002 Use of adenosine A3 receptor agonists for treatment of neuropathic pain Therapeutics
11-008 Compositions/therapy targeting neuromuscular junction Therapeutics
11-015 Adenovirus E1A fragments for use in anti-cancer therapies Therapeutics
11-017 Methods for treating inflammation Therapeutics
11-027 Use of indomethacin-based drugs to treat Cornelia de Lange Syndrome Therapeutics
11-031.1 Auto-activation of trypsin-like proteases Therapeutics
12-002
12-009
Determination of immunogenic peptides in lysosomal enzymes and induction of oral tolerance Therapeutics
12-013 Suppression of bone loss by introducing FOXP3+ CD8 T-cells Therapeutics
12-014 Aminohydantoin Compounds as Antimalarial Agents Therapeutics
13-023 Method for reducing incidence of fibrosis caused by peritoneal dialysis Therapeutics
14-002 Antibody-based therapeutics for the treatment of diabetes complications Therapeutics
14-011 Suppression of bone loss by introducing FoxP3+CD8 T-cells Therapeutics
98-003 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (HPIV-2) and vaccines based on such virus Therapeutics
99-018 Animal feed containing polypeptides Therapeutics